COVID Meets IBD: What We Know About the Vaccine
Vaccines are on everyone’s mind these days, as we hope to resume a normal life without the worries of the coronavirus shortly. But what does this mean for those living with Inflammatory Bowel Disease? What do we know about the SARS-CoV-2 vaccine when it comes to IBD?
An evening hosted by the McGill IBD Research Group, Dr. Gilaad Kaplan, Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Calgary and co-chair of Crohn’s and Colitis Canada’s COVID-IBD Taskforce who, to date, have organized for the IBD community, will discuss the impact of COVID-19 on those living with IBD and recent recommendations on the coronavirus vaccine.
Moderator: Dr. Peter Lakatos, Professor of Medicine and Director of the IBD Centre at the Ï㽶ÊÓƵ Health Centre (MUHC).
For more info and to register, click .